Vessière, Aurélia
Font, Hélène
Gabillard, Delphine
Adonis-Koffi, Laurence
Borand, Laurence
Chabala, Chishala
Khosa, Celso
Mavale, Sandra
Moh, Raoul
Mulenga, Veronica
Mwanga-Amumpere, Juliet
Taguebue, Jean-Voisin
Eang, Mao Tan
Delacourt, Christophe
Seddon, James A.
Lounnas, Manon
Godreuil, Sylvain
Wobudeya, Eric
Bonnet, Maryline
Marcy, Olivier
Funding for this research was provided by:
Unitaid (2017-15-UBx-TB-SPEED)
5% Initiative (16SANIN215)
Article History
Received: 19 January 2021
Accepted: 25 February 2021
First Online: 20 March 2021
Declarations
:
: The trial was approved by the WHO Ethics Review Committee (protocol ID: TB-Speed Pneumonia, international version 2.0 dated 22/11/2018), the French National Institute for Health and Medical Research (Inserm) Ethics Committee (IRB00003888) (protocol ID: C18–26), and national ethics committees and relevant regulatory authorities in each participating country. Written informed consent will be obtained from parents/guardians of all participants prior to enrolment.
: Not applicable.
: The authors declare that they have no competing interests.